IVM Survey Among Reproductive Medicine Specialists

NCT04488211 | Completed

• 1 other identifier: IVM Survey V2 04062020
• Study Type: observational
• Target: 200
• Locations: 1 country
• Sites: 1

Brief Summary

Although IVM as a laboratory technology in reproductive medicine has existed for many decades, there is a lack of well-designed studies comparing the efficiency and the patient satisfaction related to IVM as compared to standard ovarian stimulation for IVF. In view of this, and in order to identify unmet needs of fertility specialists with regard to the application of IVM, the investigator developed the idea of a worldwide web-based survey analysis of fertility specialists' insights and experiences regarding IVM.

Conditions

IVM

Outcome Measures

Primary Outcomes (2)

• Name of the measurement: Application of in vitro maturation (IVM) of oocytes as a laboratory tool

  Measurement tool: questionnaire; unit of measure: % of respondents who use oocyte in vitro maturation in the laboratory;

  1 month

• Name of the measurement: Appreciation of IVM as a laboratory technique

  Measurement tool: questionnaire; unit of measure: % of respondents who believe there is a role for IVM in the ART (assisted reproductive technology ) clinic

  1 month

Secondary Outcomes (1)

• Name of the measurement: Annual number of egg retrievals for IVM

  1 month

Study Arms (1)

Prospective survey respondents

Invitations to participate in the survey will be emailed on three occasions to selected fertility specialists worldwide who are affiliated to a public or private fertility clinic.

Other: Survey

Interventions

Survey OTHER

The IVM survey will be structured as a series of open questions and multiple-choice questions.

Prospective survey respondents

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Fertility specialists around the globe who are affiliated to a public or private fertility clinic. Clinics will be identified based on whether they have worked with IVM previously but stopped, and clinics with appropriate size to offer IVM competence.

You may qualify if:

• IVF clinics that have worked with IVM previously but stopped
• clinics with appropriate size to offer IVM

Sponsors & Collaborators

• Universitair Ziekenhuis Brussel: lead
• CooperSurgical Inc.: collaborator

Study Sites (1)

Universitair Ziekenhuis Brussel

Brussels, Belgium

Location

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Michel De Vos

  Universitair Ziekenhuis Brussel

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 6, 2020
• First Posted: July 27, 2020
• Study Start: July 30, 2020
• Primary Completion: December 31, 2020
• Study Completion: December 31, 2020
• Last Updated: May 4, 2021

Record last verified: 2020-06

Data Sharing

• IPD Sharing: Will not share

Locations

BE (1)